Literature DB >> 1223826

Cardiac and aortic lesions in chronic experimental poisoning with mercury vapors.

J Wojciechowski, W Kowalski.   

Abstract

The nature of the toxic influence of mercury and its effect on the cardio-vascular system are not well understood. In chronic poisoning with metallic mercury and its compounds, circulatory disorders have been observed in patients. The problem whether metallic mercury damages the endocardium and myocardium directly or indirectly through vascular changes or vegetative system stimulation remains unsolved. A study was undertaken in which a group of experimental rabbits was exposed to the chronic action of mercury vapors by inhalation and compared with a control group. Before the experiment and towards its end, ECG were taken and 24-hr urinary excretion of mercury was determined in both groups. After 3 months the animals were autopsied, and fragments of myocardium, papillary muscles, endocardium and ascending aorta were taken for histopathologic investigation. In the poisoned animals, the ECG tracings showed bradycardia. Morphologic lesions had the character of thrombosis in small and medium-caliber blood vessels, necrotic foci, thickening of the endocardium of the papillary muscles and perivalvular region and endothelial proliferation with inflammatory foci. The results indicate that, besides influencing the vegetative system, mercury vapor damages the endocardium directly and produces vascular lesions resulting in myocardial changes.

Entities:  

Mesh:

Year:  1975        PMID: 1223826

Source DB:  PubMed          Journal:  Pol Med Sci Hist Bull        ISSN: 0301-0236


  2 in total

Review 1.  Role of mercury toxicity in hypertension, cardiovascular disease, and stroke.

Authors:  Mark C Houston
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-11       Impact factor: 3.738

2.  Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease.

Authors:  Michael Sponder; Monika Fritzer-Szekeres; Rodrig Marculescu; Martina Mittlböck; Maria Uhl; Birgit Köhler-Vallant; Jeanette Strametz-Juranek
Journal:  Vasc Health Risk Manag       Date:  2014-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.